Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR2 | P41587 | 6/20 | 0.45 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.45 |
| ▸ | GLP1R | P43220 | 3/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.43 |
| ▸ | NPY4R | P50391 | 5/20 | 0.43 |
| ▸ | NPY1R | P25929 | 4/20 | 0.43 |
| ▸ | NPY2R | P49146 | 4/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9126093 | 1.00 | VIPR2 (0.45) | VIPR2VIPR1GLP1RF2C5AR1 | |
| SCHEMBL14921120 | 0.93 | VIPR2 (0.44) | VIPR2VIPR1GLP1RC5AR1NPY4R | |
| SCHEMBL9551332 | 0.93 | C5AR1 (0.46) | VIPR2VIPR1GLP1RC5AR1NPY4R | |
| SCHEMBL31612227 | 0.92 | VIPR2 (0.52) | VIPR2VIPR1GLP1R | |
| SCHEMBL30293824 | 0.92 | GLP1R (0.40) | VIPR2VIPR1GLP1RNPY4RNPY1R | |
| SCHEMBL31643038 | 0.91 | GLP1R (0.42) | VIPR2VIPR1GLP1RF2C5AR1 | |
| SCHEMBL29767364 | 0.90 | GLP1R (0.50) | VIPR2VIPR1GLP1R | |
| SCHEMBL31399748 | 0.90 | NPY4R (0.45) | VIPR2VIPR1C5AR1NPY4RNPY1R | |
| SCHEMBL31568000 | 0.89 | NPY4R (0.52) | VIPR2VIPR1GLP1RNPY4RNPY1R | |
| SCHEMBL31567997 | 0.89 | NPY4R (0.52) | VIPR2VIPR1GLP1RNPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5470569-A | Genetic engineering | CETUS ONCOLOGY CORPORATION (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0272779-B1 | New forms of colony stimulating factor-1 | CETUS ONCOLOGY CORP (US) | 1994-05-18 | — | — | EP | disclosed |
| US-5104650-A | Promoting production of interferon by monocytes; overcoming immunosuppression caused by drugs | CETUS CORPORATION (US) | 1992-04-14 | — | — | US | disclosed |
| US-4847201-A | GENETIC ENGINEERING | CETUS CORPORATION (US) | 1989-07-11 | — | — | US | disclosed |
| EP-0272779-A2 | New forms of colony stimulating factor-1 | CETUS ONCOLOGY CORPORATION (US) | 1988-06-29 | — | — | EP | disclosed |